Testosterone CYP/ENAN/PROP Injection — Class II drug recall D-330-2016
Terminated recall by Kalman Health & Wellness, Inc. dba Essential Wellness Pharma, reported 2015-11-25, distributed nationwide. Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiat
| Recall number | D-330-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Kalman Health & Wellness, Inc. dba Essential Wellness Pharma, Peoria, IL, United States |
| Recall initiated | 2015-09-03 |
| Classified | 2015-11-17 |
| Reported by FDA | 2015-11-25 |
| Terminated | 2017-12-29 |
| Distributed | Nationwide (US) |
| Quantity | 20 vials |
| Reason classes | sterility |
| Lot numbers | 062915, 071615 |
| Expiration dates | 2015-09-29, 2015-10-16 |
Product
Testosterone CYP/ENAN/PROP Injection, 66.6 mg/66.6. mg/66.6 mg/mL, 5 mL vials, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.
Reason for recall
Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-330-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.